Regulatory services

News

Regulatory context

Links and documents

Contact us

You are here : Home \ Regulatory Context FRANCE

 

Europe

 

USA

FRANCE

 

CANADA

 

MATERIOVIGILANCE (MEDICAL DEVICES)

Any incident or risk serious incident must be reported without delay to the AFSSAPS. Other adverse events may be reported on a quarterly basis and optionally. Shall be regarded as incident or risk of any incident serious incident or risk incident involving a medical device caused or likely to cause death or serious deterioration of the State of health of a patient, a user or a third party. Examples: Death, vital prognosis, permanently or important incapacity, hospitalization or prolongation of hospitalization, need for medical or surgical intervention, congenital disease.

A decision tree is enclosed in page 2 of the CERFA reporting form formulaire Cerfa n° 10246*02. Any person, manufacturer, users, or third parties (persons who are manufacturers or users or patients, the responsible for the placing on the market, distributors) with knowledge of an incident or risk of serious incident must declare.

The reporting is carried out on the form "Reporting an incident or a risk of matériovigilance incident. formulaire Cerfa n° 10246*02

It is passed to the AFSSAPS via either

o        email : dedim.ugsv@afssaps.sante.fr

o        fax au +33 (0)1.55.87.37.02,

o        or mail 143/147 boulevard Anatole France, 93 285 St Denis Cedex FRANCE

 

REACTOVIGILANCE (IN VITRO DIAGNOSTIC DEVICE)

 

Any failure or corruption of a medical diagnostic device in vitro which may cause adverse effects on human health must be the subject of a declaration of réactovigilance incident. In practice it is: indirect effect for the patient, from the clinical consequences of a wrong analysis result, of a direct effect on user due to a dangerous device

In all cases, the risk of incident must be reported in the same way as the proven incident. Healthcare users a IVDD with misleading an adverse failure must report the incident, that the IVDD is used in a laboratory for analysis (laboratory, medical offices, pharmacies...). This reporting obligation lies also to the industry (manufacturers, agents, distributors, importers) the incident occurring at a user in France and/or in another European country if this incident led to the establishment of specific measures (withdrawal of lots, information / recommendation...) the declaration takes place without delay on a specific form Download the form - Donwload the guidance to fill in the form

The report is sent to AFSSAPS either

o        by fax : +33 (0)1.55.87.42.82

o        or by mail : DEDIM, département des vigilances, Unité de réactovigilance 143-147 bd Anatole France 93285 Saint Denis Cedex FRANCE

 

 

REGISTRATION OF IIa, IIb, III et AIMD medical devices

In its missions of surveillance of the market of products placed on the market, the AFSSAPS analyzes communications received under the Decree n° 2002-1221 September 30, 2002 and Decree n°2010-270 March 15, 2010 , Download the Guidance , Download the form  Donwload the FAQ

 

REGISTRATION OF OTHER MEDICAL DEVICES

Class I, kit, class I with measuring function, sterile class I devices and custom-made devices  Download the manufacturer declaration , Download EUDAMED Guidance , Fiche d'enregistrement EUDAMED (06/10/2006) Download EUDAMED Form

 

REGISTRATION OF IN VITRO DIAGNOSTIC DEVICES

Registration of manufacturers and devices  Guidance , Download Form A , Donwload Form B , Donwload Form C

 

Clinical investigations

 

Regulatory texts

o        Public Health Law n° 2004-806 du 9 août 2004 (articles 88 à 97) du code de la santé publique.

o        Program Law  n°2006-450 dated April 18,  2006 for biomedical research (articles 31 - 33)

o        Law n° 2005-1719 December 30, 2005 (article 153)

o        Decree 2006-477 April 26, 2006, related to Biomedical research

o        Decree May 11, 2009 regarding the definitions of certain categories of biomedical research

o        Decree August 11, 2008 Conservation by the sponsor and the investigator of the documents and data for a biomedical research other than that relating to medicinal products for human use.

o        Decree March 9, 2007 content of the file to be sumbitted to ethical comitee

o        Decree August 24, 2006 fixing the procedures for presentation and content demand of substantial modification of a biomedical research involving a medical device or on a medical diagnostic device in vitro to the French Agency of health and the protection of persons Committee products safety

o        Decree August 24, 2006 procedures for reporting, the form and content of the safety of a biomedical research report involving a medical device or on a in vitro diagnostic medical device.

o        Decree August 16, 2006 the content, format and submission to French folder application biomedical health products safety agency procedures with in vitro medical device or a medical diagnostic device.

o        Decree August 16, 2006 content, format and procedures for presentation of the request for an opinion to the Committee for protection of persons in biomedical research folder on the medical device or on a medical diagnostic device in vitro.

o        Decree August 16, 2006 the form, content and modalities of adverse effects and new developments in biomedical research statements relating to medical device or to a medical diagnostic device in vitro.

o        Decree August 16, 2006 concerning the content and a biomedical research protocol submission procedures with in vitro medical device or a medical diagnostic device.

o        Decree August 16, 2006 content and presentation of a brochure for the investigator of a biomedical research with a medical device or a medical diagnostic device in vitro procedures.

o        Decree April 25, 2006 maximum indemnities as compensation for suffered constraints that a person may charge for a year for its participation in biomedical.

 

Forms and models

 

Beginning of the trial

o                    Request permission from the French Agency of health (Afssaps) and request for an opinion of the Committee on protection of individuals (CPP) for biomedical research products safety a medical device (14/11/2007) Download

o                    Letter application for authorization of biomedical research involving a medical device or a medical diagnostic device in vitro of the French health products safety agency  (Afssaps) (14/11/2007) Download

Substantial Modifications

o                    Form for request a substantial modification notification of an In vitro diagnostic device biomedical research (14/11/2007) Download 

o                    Form for request a substantial modification notification of a medical device or an In vitro diagnostic device biomedical research (14/11/2007) (14/11/2007) Download

Vigilance

o                    Vigilance report: initial report (14/11/2007) Download

o                    Vigilance report: additional information, follow-up data (26/08/2009) Download

Results

o                    Final report summary (14/11/2007) Download

End of the trial

o                    Form to declare the end of biomedical research involving a medical device or medical diagnostic device in vitro (14/11/2007) Download

 

 

 

 

© Idée Consulting - Tout droits réservés. Design par Skalpel pour Kitgrafik

 

 

 

 

Free counter and web stats